Investor Relations

CUREXO is committed to fair and transparent business management.

Financial Statement

Unit : KRW million

100,000 80,000 60,000 40,000 20,000 0
Asset
  • 2022 98,398
  • 2023 107,370
  • 2024 102,583
100,000 80,000 60,000 40,000 20,000 0
Liability
  • 2022 16,717
  • 2023 6,941
  • 2024 9,202
100,000 80,000 60,000 40,000 20,000 0
Equity
  • 2022 81,681
  • 2023 100,428
  • 2024 93,380
100,000 80,000 60,000 40,000 20,000 0
Sales
  • 2022 64,991
  • 2023 72,882
  • 2024 55,531

Balance Sheet

Unit : KRW million

Classification 2022 2023 2024
Current Asset 75,952 90,831 87,942
Non-current Asset 22,446 16,538 14,641
Asset 98,398 107,370 102,583
Current liability 16,589 4,933 7,936
Non-current liability 129 2,008 1,266
Liability 16,717 6,941 9,202
Paid in capital 19,454 20,478 20,544
Retained earnings -134,994 -140,130 -149,049
Equity 81,681 100,428 93,380

Income Statment

Unit : KRW million

Classification 2022 2023 2024
Sales 64,991 72,882 55,531
Operating income 1,111 1,135 -0
Pre-tax income -2,932 -4,759 -8,668
Net income -3,040 -4,856 -8,757